Wall Street Journal: How AI Is Transforming Drug Creation

WSJ_news

The Wall Street Journal’s Daniela Hernandez talks to BERG’s CEO Niven Narain about efforts to advance drug discovery through the use of AI. BERG’s Project Survival is featured as a key example of how we are working to improve the lives of patients.

You can read the full article here: http://on.wsj.com/2u7QfmL